VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
EVGN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
EVGNEvogene Ltd.
$0.42$4M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksEVGNPrice History

EVGN logoEvogene Ltd. (EVGN) Stock Price History

Historical prices from 2008 to 2026

$0.42-0.01  (-3.08%)close Jul 7
Returns
1M
-27.1%
3M
-48.1%
YTD
-62.4%
1Y
-67.8%
3Y
-66.0%
5Y
-57.6%
ATH$203.90Dec 2013-99.8%
ATL$0.37Jun 2026pre-split
Avg Vol (50D)1.4M/ day
52-Week Range$0.37 — $1.50
LowCurrent: $0.42High

Loading 10-year price history...

EVGN Historical Performance

1 YearTotal Return
-67.8%
Price: -67.8%
3 YearsTotal Return
-96.1%
CAGR: -66.0%
Price: -96.1%
5 YearsTotal Return
-98.6%
CAGR: -57.6%
Price: -98.6%
YTD
-62.4%

EVGN Annual Returns

Year-by-year price performance · 2008–2026

Best+318.1%2013
Worst-78.5%2024
Up years7/19
2008+2.2%
2009+92.3%
2010+13.9%
2011-26.8%
2012+14.6%
2013+318.1%
2014-52.1%
2015-12.7%
2016-37.3%
2017-39.6%
2018-42.9%
2019-30.9%
2020+181.4%
2021-67.8%
2022-61.7%
2023+15.9%
2024-78.5%
2025-43.3%
2026-22.3%
2008 annual price return
+2.2%
2009 annual price return
+92.3%
2010 annual price return
+13.9%
2011 annual price return
-26.8%
2012 annual price return
+14.6%
2013 annual price return
+318.1%
2014 annual price return
-52.1%
2015 annual price return
-12.7%
2016 annual price return
-37.3%
2017 annual price return
-39.6%
2018 annual price return
-42.9%
2019 annual price return
-30.9%
2020 annual price return
+181.4%
2021 annual price return
-67.8%
2022 annual price return
-61.7%
2023 annual price return
+15.9%
2024 annual price return
-78.5%
2025 annual price return
-43.3%
2026 annual price return
-22.3%
LessMore
Alpha vs S&P 500
1Y-90.7%
3Y-83.1%
5Y-68.9%

Price returns only.

Download Historical Data

3,986 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

EVGN Stock Price Trajectory (2008–2026)

As of July 8, 2026, Evogene Ltd. (EVGN) trades at $0.42, representing a -67.8% return over the past year. The stock has delivered a -98.6% total return over five years (-57.6% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $203.90 on December 12, 2013. From this peak, EVGN has corrected -99.8%, currently trading 55% below its 200-day moving average, suggesting potential weakness.

When compared to Healthcare sector peers PGEN (+246.5% 1Y), CDNA (+53.4% 1Y), and NTRA (+77.2% 1Y), EVGN has underperformed the peer group average. Compare EVGN vs PGEN →

EVGN Historical Price Data · from 2008

Rows 1–50 of 3,986
Date Open High Low Close Volume Change %
2026-07-070.430.440.420.4259K-3.08%
2026-07-060.430.440.410.44110K-0.07%
2026-07-020.420.450.420.4474K-0.54%
2026-07-010.440.440.420.44131K+0.48%
2026-06-300.420.440.410.44142K+1.74%
2026-06-290.390.440.390.4318K+10.93%
2026-06-260.370.400.370.390-2.31%
2026-06-250.420.430.380.401.09M-5.75%
2026-06-240.440.470.390.4233.90M-13.97%
2026-06-230.510.510.480.4973K-1.60%
2026-06-220.520.530.490.50152K-4.97%
2026-06-180.540.560.510.53223K-5.42%
2026-06-170.550.600.550.56311K-0.86%
2026-06-160.580.590.550.56174K-3.61%
2026-06-150.570.580.560.5819K-0.50%
2026-06-120.570.580.550.58125K-2.60%
2026-06-110.580.600.570.60165K+1.27%
2026-06-100.590.600.550.59211K-0.84%
2026-06-090.590.620.570.60311K+2.40%
2026-06-080.610.620.550.58385K-5.82%
2026-06-050.580.640.580.6218K+1.53%
2026-06-040.550.650.540.61731K+1.79%
2026-06-030.600.600.540.60870K+1.51%
2026-06-020.600.620.520.5924.52M-13.60%
2026-06-010.690.700.670.6837K-3.12%
2026-05-290.730.730.690.7036K-1.41%
2026-05-280.690.730.680.7234K+0.72%
2026-05-270.710.730.680.7161K+0.14%
2026-05-260.730.740.680.7174K+1.29%
2026-05-220.690.770.660.700+0.95%
2026-05-210.670.730.660.6930K-3.68%
2026-05-200.710.730.680.7296K-3.24%
2026-05-190.720.770.700.74139K+6.30%
2026-05-180.720.780.700.7069K-4.44%
2026-05-150.720.750.700.7330K-1.49%
2026-05-140.760.770.720.7429K-2.17%
2026-05-130.810.810.740.7626K-0.13%
2026-05-120.800.800.760.7648K-2.05%
2026-05-110.780.820.760.7885K+3.35%
2026-05-080.800.810.740.7553K-3.75%
2026-05-070.800.800.760.7843K-1.31%
2026-05-060.770.830.770.7992K+2.67%
2026-05-050.760.800.750.7781K+2.50%
2026-05-040.760.800.740.7543K-1.83%
2026-05-010.770.820.770.7764K-1.79%
2026-04-300.760.800.750.7846K+2.88%
2026-04-290.770.820.760.7659K-3.41%
2026-04-280.790.830.790.7964K+0.63%
2026-04-270.790.830.760.7868K-1.00%
2026-04-240.780.810.780.7942K+0.29%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

EVGN — Frequently Asked Questions

Quick answers to the most common questions about buying EVGN stock.

How has EVGN stock performed recently?

EVGN declined -67.8% over the past year, below its 5-year annualized CAGR of -57.6%. The stock trades below its 200-day moving average, reflecting the downtrend.

What is EVGN's all-time high price?

Evogene Ltd. reached $203.90 on 2013-12-12. The 52-week high is $1.50. Current 1-year return of -67.8% places the stock further from historical peaks.

Where can I download EVGN historical price data?

This page provides EVGN daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2008-2026, downloadable in CSV format.

500 data points · sampled from 3,986